Autoimmune Hepatitis Research Studies
Investigator
Open Research Studies for Autoimmune Hepatitis
GRACE: Autoimmune Hepatitis Database
Enrolling: Yes
Principle Investigator: Craig Lammert, MD
Duration: 1 visit
Patient Population: Autoimmune Hepatitis/Pre- and Post- Transplant/Overlap
Interested in this study? Please contact the coordinator below:
Kelsey Green
greenke@iu.edu
(317) 278-9292
A Randomized, Double-blind, Placebo-controlled, Phase 2a Study to Evaluate the Safety and Efficacy of Zetomipzomib (KZR-616) in Patients with Autoimmune Hepatitis
Enrolling: Yes
Principle Investigator: Craig Lammert, MD
Duration: 4 week screening period, 24 week treatment period, 4 week off-treatment safety follow-up period
Patient Population: AIH who have failed standard-of-care treatment, had an incomplete biochemical response to ≥3 months of standard-of-care treatment, or had a disease flare after standard-of-care treatment.
Drug(s): Zetomipzomib
Interested in this study? Please contact the coordinator below:
Kelsey Green
greenke@iu.edu
(317) 278-9292
Rituximab
Enrolling: Yes
Principle Investigator: Craig Lammert, MD
Duration: 12 months
Patient Population: Aged 18 or greater with AIH.
Drug(s): Rituximab
Interested in this study? Please contact the coordinator below:
Regina Weber
reginaw@iu.edu
(317) 278-3584